Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert-Jan Geersing

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Circulation|August 27, 2023
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled TrialLinda P T Joosten, Sander van Doorn, Peter M van de Ven, et al.
Journal of Thrombosis and Haemostasis : JTH|December 7, 2025
Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysisKristina Vrotniakaite-Bajerciene, Ranjeeta Mallick, Toshihiko Takada, et al.
Annals of Family Medicine|March 24, 2026
Antithrombotic Therapy Discontinuation, Bleeding, and Thromboembolic Events in Patients With Cancer During the Last Phase of Life: Insights From Primary Care RecordsDenise Abbel, Geert-Jan Geersing, Emmy M Trinks-Roerdink, et al.
European Heart Journal|July 15, 2023
Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysisNick van Es, Toshihiko Takada, Noémie Kraaijpoel, et al.
Annals of Internal Medicine|December 14, 2021
Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups : A Systematic Review and Individual-Patient Data Meta-analysisMilou A M Stals, Toshihiko Takada, Noémie Kraaijpoel, et al.
Plos Medicine|January 25, 2022
Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysisGeert-Jan Geersing, Toshihiko Takada, Frederikus A Klok, et al.
Thrombosis and Haemostasis|November 9, 2021
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysisFaizan Khan, Alvi Rahman, Tobias Tritschler, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2025
Safety and efficiency of diagnostic strategies for ruling out pulmonary embolism in patients with chronic lung disease: an individual-patient data meta-analysisVicky Mai, Toshihiko Takada, Noemie Kraaijpoel, et al.
Hemasphere|May 20, 2025
Quality of vitamin K antagonist treatment during the last year of lifeChantal Visser, Eva K Kempers, Jamilla Goedgebuur, et al.
Thrombosis and Haemostasis|January 24, 2025
Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting DiseaseEva K Kempers, Chantal Visser, Eric C T Geijteman, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Circulation|August 27, 2023
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled TrialLinda P T Joosten, Sander van Doorn, Peter M van de Ven, et al.
Journal of Thrombosis and Haemostasis : JTH|December 7, 2025
Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysisKristina Vrotniakaite-Bajerciene, Ranjeeta Mallick, Toshihiko Takada, et al.
Annals of Family Medicine|March 24, 2026
Antithrombotic Therapy Discontinuation, Bleeding, and Thromboembolic Events in Patients With Cancer During the Last Phase of Life: Insights From Primary Care RecordsDenise Abbel, Geert-Jan Geersing, Emmy M Trinks-Roerdink, et al.
European Heart Journal|July 15, 2023
Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysisNick van Es, Toshihiko Takada, Noémie Kraaijpoel, et al.
Annals of Internal Medicine|December 14, 2021
Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups : A Systematic Review and Individual-Patient Data Meta-analysisMilou A M Stals, Toshihiko Takada, Noémie Kraaijpoel, et al.
Plos Medicine|January 25, 2022
Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysisGeert-Jan Geersing, Toshihiko Takada, Frederikus A Klok, et al.
Thrombosis and Haemostasis|November 9, 2021
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysisFaizan Khan, Alvi Rahman, Tobias Tritschler, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2025
Safety and efficiency of diagnostic strategies for ruling out pulmonary embolism in patients with chronic lung disease: an individual-patient data meta-analysisVicky Mai, Toshihiko Takada, Noemie Kraaijpoel, et al.
Hemasphere|May 20, 2025
Quality of vitamin K antagonist treatment during the last year of lifeChantal Visser, Eva K Kempers, Jamilla Goedgebuur, et al.
Thrombosis and Haemostasis|January 24, 2025
Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting DiseaseEva K Kempers, Chantal Visser, Eric C T Geijteman, et al.
Pageof 13